The MeChaNiSM network connects world-leading academic laboratories in the fields of single-molecule biophysics, organic synthesis, and molecular modeling with key industrial partners (pharma and scientific instrumentation) creating a unique environment to train 15 Doctoral Candidates (DCs) in cross-disciplinary skills. These DCs will be vital to establish new technology in nucleic acids chemistry and single-molecule analysis in industrial research, in particular for pharmaceutical and biotechnological industries, in the design of new drugs — including RNA therapeutics — and technologies to improve human health.
Chalmers leads EU-initiative on future medicines
RNA-based drugs hold immense potential and are of great interest to both society and the pharmaceutical industry. However, to tackle the current challenges, there is a need for increased knowledge about RNA. Techniques that analyze RNA molecules individually can enhance our understanding of their fundamental properties, potentially accelerating drug development. EU is now funding a project coordinated by Chalmers University of Technology to train PhD students with specialized expertise in this research area.
Horizon Europe 2021-2027 Framework Programme, Grant Agreement number 101168851
Disclaimer: Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. The European Union cannot be held responsible for them.